Insider · CIK 0001850525
Matthew Joseph Kappers
Files at CRTG (CORETEC GROUP INC.), AMPG (AmpliTech Group, Inc.). First filing -, latest -.
In brief
Matthew Joseph Kappers files SEC Form 4 as director and CEO at CRTG (CORETEC GROUP INC.), and also at AMPG (AmpliTech Group, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Matthew Joseph Kappers has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 19, 2024 | AMPG AmpliTech Group, Inc. | AGrant or award Common Stock | +15,000 | $2.00 | $30k | 45,000 | Dec 23, 2024 |
| Oct 27, 2023 | CRTG CORETEC GROUP INC. | AGrant or award Option (right to buy)derivative | +5,000,000 | $0.00 | $0 | 5,000,000 | Oct 31, 2023 |
Questions about Matthew Joseph Kappers
Answered from the filings on this page, as of the latest one.
Is Matthew Joseph Kappers buying or selling?
Matthew Joseph Kappers has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Matthew Joseph Kappers's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Matthew Joseph Kappers has 0.
Where does Matthew Joseph Kappers file Form 4?
Matthew Joseph Kappers has filed Form 4 at CRTG (CORETEC GROUP INC.) as Chief Executive Officer; AMPG (AmpliTech Group, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.